Monday June 26th 2017

Archive for March, 2013

‘Liberation’ treatment offers no sustained improvement for MS: study

‘Liberation’ treatment offers no sustained improvement for MS: study

A small clinical trial of the so-called “liberation treatment” for multiple sclerosis has found that the intervention did not improve patients’ symptoms and in some cases even made their disease worse, researchers say. The University of Buffalo study of 30 [Read More]

Latest Topics

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Best multiple sclerosis blogs

Best multiple sclerosis blogs

Multiple sclerosis blogs are both helpful and inspirational for people affected by the disease. We have selected the 10 [Read More]